Oncogene - Table of Contents alert Volume 32 Issue 38

Advertisement Finally! Antibodies you can TRUST. Partnering with epigenetics experts including the BLUEPRINT Epigenome consortium, Diagenode has developed the absolute best epigenetics antibodies with the highest specificity and sensitivity available. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with validated antibodies you can trust. Learn more. TABLE OF CONTENTS Volume 32, Issue 38 (September 2013) In this issue Review Original Articles Short Communications Oncogenomics Also new AOP Advertisement Just one of many high-quality articles from Frontiers in Oncology: Protease addiction and synthetic lethality in cancer (open access) In this perspective, José M. P. Freije, Julia M. Fraile and Carlos López-Otín focus on the importance of proteolytic enzymes to maintain the viability of cancer cells and hypothesize that most tumors present "addiction" to a number of proteolytic activities, which in turn may represent valuable targets of anti-cancer therapies. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Special section on epigenomics The special section on epigenomics in the July 2013 issue of Journal of Human Genetics features review and original articles by top-level epigenetic researchers, and covers various topics of epigenetic research, both basic and clinical.  Take advantage of FREE access to select articles today!  Review Top Genetic instability: tipping the balance A Janssen and R H Medema Oncogene 2013 32: 4459-4470; advance online publication, December 17, 2012; 10.1038/onc.2012.576 Abstract | Full Text Original Articles Top A non-cell-autonomous tumor suppressor role for Stat in eliminating oncogenic scribble cells M C Schroeder, C-L Chen, K Gajewski and G Halder Oncogene 2013 32: 4471-4479; advance online publication, October 29, 2012; 10.1038/onc.2012.476 Abstract | Full Text RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance H Ray-David, Y Romeo, G Lavoie, P Déléris, J Tcherkezian, J A Galan and P P Roux Oncogene 2013 32: 4480-4489; advance online publication, October 29, 2012; 10.1038/onc.2012.472 Abstract | Full Text BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor β (TGF-β1) in colorectal tumour cells V R Skeen, T J Collard, S L Southern, A Greenhough, A Hague, P A Townsend, C Paraskeva and A C Williams Oncogene 2013 32: 4490-4499; advance online publication, October 29, 2012; 10.1038/onc.2012.480 Abstract | Full Text Loss of MUTYH function in human cells leads to accumulation of oxidative damage and genetic instability V Ruggieri, E Pin, M T Russo, F Barone, P Degan, M Sanchez, M Quaia, A Minoprio, E Turco, F Mazzei, A Viel and M Bignami Oncogene 2013 32: 4500-4508; advance online publication, October 29, 2012; 10.1038/onc.2012.479 Abstract | Full Text Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells Y-H Lin, C-J Liao, Y-H Huang, M-H Wu, H-C Chi, S-M Wu, C-Y Chen, Y-H Tseng, C-Y Tsai, I-H Chung, T-I Wu, M-M Tsai, C D Lin and K-H Lin Oncogene 2013 32: 4509-4518; advance online publication, August 5, 2013; 10.1038/onc.2013.309 Abstract | Full Text CpG island shore methylation regulates caveolin-1 expression in breast cancer OPEN X Rao, J Evans, H Chae, J Pilrose, S Kim, P Yan, R-L Huang, H-C Lai, H Lin, Y Liu, D Miller, J-K Rhee, Y-W Huang, F Gu, J W Gray, TH-M Huang and K P Nephew Oncogene 2013 32: 4519-4528; advance online publication, November 5, 2012; 10.1038/onc.2012.474 Abstract | Full Text 5-Fluorouracil signaling through a calcium–calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells G Can, B Akpinar, Y Baran, B Zhivotovsky and M Olsson Oncogene 2013 32: 4529-4538; advance online publication, October 29, 2012; 10.1038/onc.2012.467 Abstract | Full Text PKCδ-mediated phosphorylation of BAG3 at Ser187 site induces epithelial−mesenchymal transition and enhances invasiveness in thyroid cancer FRO cells N Li, Z-X Du, Z-H Zong, B-Q Liu, C Li, Q Zhang and H-Q Wang Oncogene 2013 32: 4539-4548; advance online publication, October 29, 2012; 10.1038/onc.2012.466 Abstract | Full Text HIF-independent role of prolyl hydroxylases in the cellular response to amino acids OPEN R V Durán, E D MacKenzie, H Boulahbel, C Frezza, L Heiserich, S Tardito, O Bussolati, S Rocha, M N Hall and E Gottlieb Oncogene 2013 32: 4549-4556; advance online publication, October 22, 2012; 10.1038/onc.2012.465 Abstract | Full Text GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21 U E Lang, P Kocabayoglu, G Z Cheng, Z Ghiassi-Nejad, U Muñoz, D Vetter, D A Eckstein, R A Hannivoort, M J Walsh and S L Friedman Oncogene 2013 32: 4557-4564; advance online publication, October 22, 2012; 10.1038/onc.2012.457 Abstract | Full Text Short Communications Top DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats H-X Yan, H-P Wu, H-L Zhang, C Ashton, C Tong, J Wu, Q-J Qian, H-Y Wang and Q-L Ying Oncogene 2013 32: 4565-4571; advance online publication, October 15, 2012; 10.1038/onc.2012.451 Abstract | Full Text Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells R Amato, D Scumaci, L D'Antona, R Iuliano, M Menniti, M Di Sanzo, M C Faniello, E Colao, P Malatesta, A Zingone, V Agosti, F S Costanzo, A M Mileo, M G Paggi, F Lang, G Cuda, P Lavia and N Perrotti Oncogene 2013 32: 4572-4578; advance online publication, October 29, 2012; 10.1038/onc.2012.470 Abstract | Full Text β-Catenin signaling dosage dictates tissue-specific tumor predisposition in Apc-driven cancer E R M Bakker, E Hoekstra, P F Franken, W Helvensteijn, C H M van Deurzen, W van Veelen, E J Kuipers and R Smits Oncogene 2013 32: 4579-4585; advance online publication, October 8, 2012; 10.1038/onc.2012.449 Abstract | Full Text Oncogenomics Top Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells N Chapman-Rothe, E Curry, C Zeller, D Liber, E Stronach, H Gabra, S Ghaem-Maghami and R Brown Oncogene 2013 32: 4586-4592; advance online publication, November 5, 2012; 10.1038/onc.2012.477 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.